Marker Therapeutics, Inc. (MRKR)
1.66
+0.05
(+3.11%)
USD |
NASDAQ |
Apr 17, 16:00
1.67
+0.01
(+0.60%)
After-Hours: 20:00
Marker Therapeutics SG&A Expense (Quarterly) : 0.8466M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 33.67M |
| Tenaya Therapeutics, Inc. | 5.977M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| electroCore, Inc. | 10.19M |
| Agenus, Inc. | 12.30M |